Hemovent closed a Series A round (amount undisclosed) in Jul 2017. The company is based in Germany. Investors in the round: 1st Capital Partner. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
